Lycia Therapeutics Inc.
LYCAHealthcare|Biotechnology|US
$30.50
+1.70 (+5.90%)
Clinical Trials (1)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07701954 Single Ascending and Multiple Ascending Dose Study of LCA-0061 | Atopic Disease, Peanut Allergies | P1 | Recruiting | 72 | RCT, Double-blind | LCA-0061, Placebo |